As Opponents Predicted, ‘Right To Try’ Law Fizzles Without Drugmakers’ Buy-In

Drugmakers prefer to have their products go through the FDA approval process. “At the end of the day, [companies] control their products. It’s their property. You can pass a law saying people can try things, but unless you obligate companies to give something, there’s no right to gain access,” said Arthur Caplan, who heads the division of medical ethics at the NYU School of Medicine.

from Kaiser Health News https://ift.tt/32GosLu